These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24315565)

  • 1. Mobilization of viable tumor cells into the circulation during radiation therapy.
    Martin OA; Anderson RL; Russell PA; Cox RA; Ivashkevich A; Swierczak A; Doherty JP; Jacobs DH; Smith J; Siva S; Daly PE; Ball DL; Martin RF; MacManus MP
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):395-403. PubMed ID: 24315565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracking viable circulating tumor cells (CTCs) in the peripheral blood of non-small cell lung cancer (NSCLC) patients undergoing definitive radiation therapy: pilot study results.
    Dorsey JF; Kao GD; MacArthur KM; Ju M; Steinmetz D; Wileyto EP; Simone CB; Hahn SM
    Cancer; 2015 Jan; 121(1):139-49. PubMed ID: 25241991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Tumor Cell Assessment in Presumed Early Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy: A Prospective Pilot Study.
    Frick MA; Kao GD; Aguarin L; Chinniah C; Swisher-McClure S; Berman AT; Levin WP; Cengel KA; DeCesaris C; Hahn SM; Dorsey JF; Simone CB
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):536-542. PubMed ID: 30244877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancer.
    Tan CL; Lim TH; Lim TKh; Tan DS; Chua YW; Ang MK; Pang B; Lim CT; Takano A; Lim AS; Leong MC; Lim WT
    Oncotarget; 2016 Apr; 7(17):23251-62. PubMed ID: 26993609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer.
    Zhou J; Dong F; Cui F; Xu R; Tang X
    Cancer Chemother Pharmacol; 2017 Apr; 79(4):825-833. PubMed ID: 28289866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation Therapy Modulates DNA Repair Efficiency in Peripheral Blood Mononuclear Cells of Patients With Non-Small Cell Lung Cancer.
    Yin X; Mason J; Lobachevsky PN; Munforte L; Selbie L; Ball DL; Martin RF; Leong T; Siva S; Martin OA
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):521-531. PubMed ID: 30312716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy for Non-Small Cell Lung Cancer Induces DNA Damage Response in Both Irradiated and Out-of-field Normal Tissues.
    Siva S; Lobachevsky P; MacManus MP; Kron T; Möller A; Lobb RJ; Ventura J; Best N; Smith J; Ball D; Martin OA
    Clin Cancer Res; 2016 Oct; 22(19):4817-4826. PubMed ID: 27259562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
    Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
    J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
    Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
    Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Released Circulating Tumor Cells During Surgery for Non-Small Cell Lung Cancer.
    Tamminga M; de Wit S; van de Wauwer C; van den Bos H; Swennenhuis JF; Klinkenberg TJ; Hiltermann TJN; Andree KC; Spierings DCJ; Lansdorp PM; van den Berg A; Timens W; Terstappen LWMM; Groen HJM
    Clin Cancer Res; 2020 Apr; 26(7):1656-1666. PubMed ID: 31772122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of the DNA damage response by transforming growth factor-beta inhibitors enhances radiation sensitivity of non-small-cell lung cancer cells in vitro and in vivo.
    Du S; Bouquet S; Lo CH; Pellicciotta I; Bolourchi S; Parry R; Barcellos-Hoff MH
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):91-9. PubMed ID: 25835621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial.
    Yanagita M; Redig AJ; Paweletz CP; Dahlberg SE; O'Connell A; Feeney N; Taibi M; Boucher D; Oxnard GR; Johnson BE; Costa DB; Jackman DM; Jänne PA
    Clin Cancer Res; 2016 Dec; 22(24):6010-6020. PubMed ID: 27281561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.
    Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer.
    Chen X; Wang X; He H; Liu Z; Hu JF; Li W
    PLoS One; 2015; 10(5):e0126276. PubMed ID: 25996878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal circulating tumor cells (CTCs) and OCT4 mRNA expression in CTCs for prognosis prediction in patients with non-small-cell lung cancer.
    Li S; Chen Q; Li H; Wu Y; Feng J; Yan Y
    Clin Transl Oncol; 2017 Sep; 19(9):1147-1153. PubMed ID: 28374320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection.
    Bayarri-Lara C; Ortega FG; Cueto Ladrón de Guevara A; Puche JL; Ruiz Zafra J; de Miguel-Pérez D; Ramos AS; Giraldo-Ospina CF; Navajas Gómez JA; Delgado-Rodriguez M; Lorente JA; Serrano MJ
    PLoS One; 2016; 11(2):e0148659. PubMed ID: 26913536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
    Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An approach of selecting appropriate markers from the primary tumor to enable detection of circulating tumor cells in patients with non-small cell lung cancer.
    Warawdekar UM; Sirajuddin MM; Pramesh CS; Mistry RC
    J BUON; 2015; 20(3):782-90. PubMed ID: 26214631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitor NVP-LAQ824 sensitizes human nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation.
    Cuneo KC; Fu A; Osusky K; Huamani J; Hallahan DE; Geng L
    Anticancer Drugs; 2007 Aug; 18(7):793-800. PubMed ID: 17581301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Tumor Cells with Aberrant
    Pailler E; Oulhen M; Borget I; Remon J; Ross K; Auger N; Billiot F; Ngo Camus M; Commo F; Lindsay CR; Planchard D; Soria JC; Besse B; Farace F
    Cancer Res; 2017 May; 77(9):2222-2230. PubMed ID: 28461563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.